Evidence map›Paper›PMID 41353656›Full record

ArticleBioethics2026

Liminal Bioethics for Liminal Statuses: A New Method for Analysing Novel Biological Entities.

Michael Wee, Ilina Singh

Abstract read
In one paragraph

Article in Bioethics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Michael WeeEthox Centre, University of Oxford, Oxford, UK.ORCID 0000-0002-1393-6313
Ilina SinghNeuroscience, Ethics & Society (NEUROSEC), Department of Psychiatry, University of Oxford, Oxford, UK.

Funding

Rare genetic disorders in NeuroDev: Insight into the genetic and phenotypic heterogeneity of ID, ASD and ADHD in South African PopulationsU01MH119689 · NIMH · BROAD INSTITUTE, INC. · PI DONALD, KIRSTY, O'DONNELL-LURIA, ANNE · 2019 to 2023
$5.2M
NIMH NIH HHS U01 MH119689This study was funded in whole, or in part, by the Wellcome Trust [203132/Z/16/Z and 226801/Z/22/Z] and the National Institute of Mental Health of the National Institutes of Health [award number U01MH119689].Wellcome Trust 203132Wellcome Trust 226801
6 · The paper itself

Abstract

Novel biological entities such as cell lines and organoids do not typically fit into established conceptual categories, such as 'human' or 'nonhuman', 'gift' or 'property'. This makes developing robust ethical principles or policy solutions difficult. In this article, we present a new approach to the ethics of novel biological entities, which we call 'liminal bioethics'. We argue that some entities are best understood as liminal; we should not try to shoehorn them into existing categories or modify our concepts to suit them. However, we must investigate which concepts help articulate an entity's liminal status most precisely. The choice of concepts, in turn, may suggest correspondingly liminal ethical principles or solutions for that entity. To demonstrate how this method works, we focus on immortalised cell lines as a test case, while also considering its implications for more recent breakthroughs in cell culture technology relating to organoids and assembloids. First, we demonstrate why the gift-property distinction is inadequate for framing the liminality of cell lines. We then argue for cell lines as being located in a liminal conceptual space between body part and organism, and discuss the conceptual shift that this entails for understanding the status of cell lines and organoids. We suggest that ethical principles in relation to cell lines should reflect this particular liminality; for example, commercial exchange of cell lines seems more acceptable than with body parts, but some means of respecting cell lines' continuing human connection should still be in place.

Indexed as

BioethicsOrganoidsBioethical IssuesCell Culture TechniquesCell LineHumans

Identifiers

PMID41353656
PMCPMC7618663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.